Ajinomoto

Ajinomoto Co. is a prominent Japanese manufacturer known for its high-quality seasonings, processed foods, beverages, and amino acids. Founded in 1909, the company utilizes advanced amino acid fermentation technologies to develop its products, which include dry soup mixes, frozen foods, and monosodium glutamate (MSG). Ajinomoto serves both consumers and global food manufacturers, with the food sector accounting for about three-quarters of its sales and a significant portion of its profits, primarily generated overseas. In addition to its food business, Ajinomoto focuses on healthcare and functional materials, positioning these non-food segments as key growth drivers through 2030. The company is dedicated to enhancing food resources, human health, and global sustainability, striving to provide unique value to customers while contributing positively to society.

Ryuichi Mihara

Associate General Manager

11 past transactions

Ascend supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.

On The Slope

Series G in 2021
On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.

DAIZ

Series B in 2020
DAIZ Inc. is a company based in Kumamoto, Japan, specializing in the production and supply of plant-based meat alternatives. Founded in 2015, DAIZ focuses on the research and development, as well as the manufacturing and sale of raw materials derived from germinated soybeans. The company aims to provide plant-based substitutes for traditional meat dishes, offering consumers a healthy and cruelty-free alternative. Through its innovative use of soybean-derived functional substances, DAIZ contributes to the growing demand for sustainable and nutritious food options.
Granules OmniChem Private Limited is a pharmaceutical company that specializes in contract development and active pharmaceutical ingredient (API) manufacturing services. Established in 2011 and headquartered in Visakhapatnam, India, the company operates as a joint venture between Granules India Limited and S.A. Ajinomoto OmniChem N.V. As of May 2020, it functions as a subsidiary of S.A. Ajinomoto OmniChem N.V., focusing on providing high-quality services in the pharmaceutical sector.

Cambrooke Therapeutics

Acquisition in 2017
Cambrooke Therapeutics specializes in the development and manufacture of innovative clinical nutrition products designed for patients with specialized dietary needs. The company focuses on providing natural intact protein products that address the dietary management requirements of individuals with metabolic disorders, renal diseases, and phenylketonuria. By offering patient-centered therapeutic nutrition, Cambrooke Therapeutics aims to enhance the dietary experiences of those who require medical supervision for their nutritional intake, ensuring effective treatment for conditions that hinder the breakdown of specific amino acids.

Hinoman

Series B in 2017
Hinoman helps meet the soaring global demand for healthy, secure and sustainable food, with an innovative all-natural highly nutritional-source plant cultivated with breakthrough technology. Hinoman is ushering in the future of nutrition—with mankai, the all-natural protein- and vitamin-packed proprietary plant, grown with sophisticated precision agriculture. Hinoman is passionate about propagating this safe food source. The company’s perpetual growth technology promotes scalability for GloCal consumption while minimizing the environmental footprint.

GeneDesign

Acquisition in 2016
GeneDesign, Inc. is an oligonucleotide manufacturer based in Osaka, Japan, founded in 2000. The company specializes in the synthesis of DNA, RNA, and LNA oligonucleotides, offering a wide range of production capacities from micro mole to gram scale. GeneDesign focuses on manufacturing nucleic acid drugs and providing research services, thereby enabling clients to access high-quality pharmaceutical products and research support. As of December 31, 2016, it operates as a subsidiary of Ajinomoto Co., Inc.

Orgen

Acquisition in 2016
Orgen Gida Sanayi ve Ticaret A.S., founded in 1981 and based in Izmir, Turkey, specializes in the production of seasonings and packaged food products. The company has established itself in the food industry and operates as a subsidiary of Ajinomoto Co., Inc. Since its inception, Orgen has focused on delivering a variety of culinary products that cater to diverse consumer needs.

Promasidor

Secondary Market in 2016
Promasidor (South Africa) (Pty) Ltd. is a prominent manufacturer and supplier of dairy products, beverages, and food enhancement products, including a non-dairy creamer. Founded in 1979 by Robert Rose, the company is headquartered in Bryanston, South Africa, and operates across 36 countries in Africa. Its extensive product range includes powdered beverages, flavor seasonings, powdered milk, cereals, and other processed foods. Promasidor is particularly active in key markets such as Nigeria, the Democratic Republic of the Congo, Ghana, Algeria, and Angola, offering affordable, high-quality products that cater to the diverse needs of consumers in the region.

Windsor Foods

Acquisition in 2014
Windsor Foods is a prominent manufacturer and marketer of frozen ethnic foods and appetizers, headquartered in Houston, Texas. The company specializes in a diverse range of culinary offerings, including Italian cuisine, Pan-Asian appetizers, Southwestern comfort foods, and Mexican mainstays. With a commitment to maintaining high-quality standards in frozen food production, Windsor Foods has established a strong reputation in the market, supported by a rich heritage of 250 years. The company aims to provide clients with a single source for a variety of international dishes that are convenient and easy to serve, ensuring customer satisfaction through a focus on quality and service.

Althea Technologies

Acquisition in 2013
Althea Technologies, based in San Diego, CA, is a contract development and manufacturing organization that serves the pharmaceutical and biotechnology industries. The company specializes in cGMP manufacturing, analytical development, and aseptic filling services for both vials and syringes. Althea Technologies also offers gene expression analysis utilizing eXpress Profiling technology and quantitative PCR testing. Additionally, it focuses on the production of microbial-derived recombinant proteins and plasmid DNA, catering to both early-stage and commercial requirements within a single facility.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.